Alpha Fetoprotein, Total and L3 Percent
| Label Mnemonic: | AFPL3 |
| Epic code: | LAB8106 |
| Downtime form: | Doctor/Provider Orders - Pathology Core and Specialty Care Nursery |
Commercial Mailout Laboratory
6240-8 RCP
356-8593
6240-8 RCP
356-8593
Specimen(s):
Serum
Collection Medium:
 |
| Red top tube 5 mL (Clot Activator) |
Minimum:
Preferred Minimum: 1 mL serum
Absolute Minimum: 0.5 mL serum
Absolute Minimum: 0.5 mL serum
Rejection Criteria:
Plasma
Turn Around
Time:
1-5 days upon receipt at reference laboratory
Reference Range:
By report
Interpretive Data:
The μTASWako method is used. Results obtained with different assay
methods or kits cannot be used interchangeably. The AFP L3 Percent
assay is intended as a risk assessment for the development of
hepatocellular carcinoma in patients with chronic liver diseases.
Patients with elevated serum AFP-L3 percent should be more intensely
evaluated for evidence of hepatocellular carcinoma since elevated
values have been shown to be associated with a seven-fold increase in
the risk for developing hepatocellular carcinoma within 21 months. For
pregnant females, the result is not interpretable as a tumor marker.
Methodology:
Quantitative Liquid Chromatography/Immunoassay
CPT Code:
82107